Artículos científicos Open Access

Testing for SARS-CoV-2 antibodies
The BMJ
Jessica Watson, et al
Prospects for SARS-CoV-2 diagnostics, therapeutics and vaccines in Africa
Nature Reviews Microbiology
Margolin, E., Burgers, W.A., Sturrock, E.D. et al.
Substantial underestimation of SARS-CoV-2 infection in the United States
Nature Communications
Wu, S.L., Mertens, A.N., Crider, Y.S. et al.
Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies
Nature Microbiology
Lee, W.S., Wheatley, A.K., Kent, S.J. et al
The coding capacity of SARS-CoV-2
Nature
Finkel, Y., Mizrahi, O., Nachshon, A. et al.
SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation
Nature Structural & Molecular Biology
Schubert, K., Karousis, E.D., Jomaa, A. et al.
A role for Biofoundries in rapid development and validation of automated SARS-CoV-2 clinical diagnostics
Nature Communications
Crone, M.A., Priestman, M., Ciechonska, M. et al
Storm of soluble immune checkpoints associated with disease severity of COVID-19
Signal Transduction and Targeted Therapy
Kong, Y., Wang, Y., Wu, X. et al.

Página 331 de 490

Síguenos en nuestras redes sociales

Suscríbete a nuestro Boletín Institucional
INSP logo
© 2022 INSP. Todos los derechos reservados.